(Q46634207)

23 December 2017

meta-analysis

0 references

title

PGE1 and other prostaglandins in the treatment of intermittent claudication: a meta-analysis (English)

1 reference

23 December 2017

intermittent claudication

main subject

1 reference

1 reference

Klaus Amendt

1

1 reference

23 December 2017

publication date

1 July 2005

1 reference

23 December 2017

published in

Angiology

1 reference

23 December 2017

volume

56

1 reference

23 December 2017

issue

4

1 reference

23 December 2017

page(s)

409-415

1 reference

23 December 2017

A dose-effect study of beraprost sodium in intermittent claudication

cites work

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600408

Intensive vascular training in stage IIb of peripheral arterial occlusive disease. The additive effects of intravenous prostaglandin E1 or intravenous pentoxifylline during training

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600408

Prostanoids in the treatment of intermittent claudication--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600408

Pharmacologic treatment for intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600408

Medical treatment of peripheral arterial disease and claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600408

Clinical effects of intravenous iloprost in patients with intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331970505600408

10.1177/000331970505600408

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017